
The health benefits of aggressive blood pressure control outweigh the potential risks for seniors, according to the latest results from a major clinical trial. About 85% of seniors treated to a target blood pressure of 120 systolic (the top number in a blood pressure reading) had a positive net benefit from such tight control, researchers reported. The reduced risk of heart disease and early death outweighed the negatives that can accompany such aggressive treatment, which include potential kidney damage or dangerously low blood pressure, results show. “Almost all … participants aged 65 years or greater had a predicted net benefit that favored an systolic blood pressure target of less than 120 mm Hg over a systolic blood pressure target of less than 140 mm Hg,” concluded the research team led by senior investigator Dr. Simon Ascher, an assistant clinical professor with the University of California-Davis. Systolic blood pressure refers to pressure within blood vessels during a heartbeat. Elderly patients, frail seniors and those taking many different medications derived “greater absolute harms from intensive blood pressure lowering,” along with greater heart disease, cognitive and death rate benefits, the study found. These results come from the Systolic Blood Pressure Intervention Trial (SPRINT), which in 2017 led major U.S. cardiology groups to revise their definition of high blood pressure. As a result, blood pressure of 130 systolic has… read on > read on >